Avoiding falls with Parkinson’s disease
This article discusses the effects of Parkinson’s on balance and offers practical advice on how to avoid falls and maintain mobility.
One Day in Parkinsons Life
The historical development of the understanding of Parkinson’s disease, from the discovery by James Parkinson to modern treatment approaches.
Parkinson’s disease is known worldwide today, but this was not always the case. The history of this disease goes back a long way and is closely linked to the British physician James Parkinson, who first described the disease in 1817. Since then, the understanding of the disease has evolved considerably. In this article, we take a look at the historical milestones in Parkinson’s research and show how knowledge about the disease has changed from its beginnings to the present day.
In 1817, the British physician James Parkinson published a treatise entitled “An Essay on the Shaking Palsy”, in which he described a previously unknown disease characterised by tremors, slow movements and muscle stiffness. In this work, he laid the foundation for what is now known as Parkinson’s disease. Although James Parkinson only described six cases, including people he simply observed on the streets of London, he recognised that it was a disease in its own right, distinct from other motor disorders.
What James Parkinson did not know, however, was the exact cause of the disease. He surmised that it was caused by damage to the nervous system, but was unable to prove this at the time. It was not until many years later that scientists succeeded in deciphering the exact pathophysiology of the disease.
James Parkinson’s work shows how important clinical observation is for medical progress. Even if he didn’t have all the answers, he showed a willingness to recognise and document new symptoms and clinical pictures. His work reminds me how crucial it is to pay attention to subtle changes in behaviour or health, especially in diseases like Parkinson’s whose symptoms often develop insidiously.
After James Parkinson’s discovery, the disease was largely forgotten until the famous French neurologist Jean-Martin Charcot became aware of Parkinson’s work in the late 19th century. Charcot, who is often referred to as the father of modern neurology, deepened the understanding of the disease and coined the term “Parkinson’s disease” in honour of James Parkinson.
Charcot recognised that the disease not only caused tremors, but was also characterised by muscle stiffness and slowness of movement. He also emphasised that not all patients with Parkinson’s showed tremors as a symptom, which was an important differentiation that is still relevant today.
In the 20th century, technological advances in biology and neurology made the exact causes of Parkinson’s disease increasingly clear. A key breakthrough came in the 1950s when scientists realised that the loss of dopamine-producing nerve cells in an area of the brain known as the substantia nigra was the main cause of the motor symptoms of Parkinson’s disease.
The discovery of dopamine as an important neurotransmitter that controls movement revolutionised the understanding of the disease. Researchers could now clearly recognise that the lack of dopamine led to the classic symptoms such as tremors, muscle stiffness and slow movements. This discovery formed the basis for the modern treatment of Parkinson’s disease.
It’s fascinating to see how knowledge about Parkinson’s has developed over time. When I looked into the history of the disease, I realised how slowly scientific knowledge sometimes progresses. The discovery of dopamine as a central factor in Parkinson’s was a milestone that changed the treatment options for patients worldwide. It shows how important patience and perseverance are in medical research.
A significant advance in the treatment of Parkinson’s disease was the development of the drug Levodopa (L-Dopa) in the 1960s. L-dopa is a precursor of dopamine and can cross the blood-brain barrier, meaning that it is converted into dopamine in the brain. This was revolutionary as it was the first treatment that could effectively alleviate the symptoms of the disease.
Levodopa remains the most effective drug for treating Parkinson’s disease today, although it can lose its effectiveness over time and can cause side effects such as dyskinesia (involuntary movements).
I have met several people who use levodopa to treat their Parkinson’s symptoms. The improvement in their mobility and quality of life was often impressive, especially in the early stages of the disease. However, I also noticed that the side effects increased over the years. This is a reminder that despite their effectiveness, medical treatments often bring challenges that need to be managed individually.
In the 1990s, deep brain stimulation (DBS) was introduced as an alternative treatment method for Parkinson’s disease. This technique involves inserting electrodes into specific areas of the brain to regulate electrical activity. Patients who no longer respond well to medication such as levodopa can benefit from this method.
Deep brain stimulation is not curative, but it can significantly alleviate symptoms and improve patients’ quality of life. It is usually used for patients who have suffered from Parkinson’s for several years and for whom medication is no longer as effective.
Deep brain stimulation is a fascinating example of the use of modern technology in medicine. The idea that electrical impulses can help the brain to function better is impressive and shows how far medical research has come. I remember how excited some patients were when they talked about this treatment option – it offers hope for those who no longer respond adequately to conventional medication.
In recent decades, Parkinson’s research has broken new ground, particularly in the field of genetics. Around 15% of Parkinson’s cases are genetic, and scientists are working to identify the genetic mutations associated with the disease. This opens up the possibility of personalised medicine, where treatments are tailored to the individual genetic profiles of patients.
Another promising area of research is the development of biomarkers that could enable an earlier diagnosis of Parkinson’s disease. Currently, Parkinson’s is often not diagnosed until a significant loss of dopamine-producing cells has already occurred. Biomarkers could help to recognise the disease at a much earlier stage and thus enable earlier interventions.
The history of Parkinson’s disease is a story of scientific progress and hope. From the first clinical observations by James Parkinson to modern treatments such as levodopa and deep brain stimulation, our understanding of the disease has advanced enormously. At the same time, much remains to be done, particularly in the areas of early diagnosis and personalised medicine.
Looking at the progress made over the last 200 years, we can be optimistic about the future. Research is constantly progressing and it is quite possible that future generations of Parkinson’s patients will benefit from even more effective treatments.
Parkinson’s may be a challenging disease, but the constant progress in research shows us that there is always hope, and that each discovery brings us closer to a better understanding and better treatment options.
This article discusses the effects of Parkinson’s on balance and offers practical advice on how to avoid falls and maintain mobility.
A detailed look at the different stages of Parkinson’s disease and how sufferers can prepare for each stage to maintain their quality of life.
This article explains how patients and relatives can prepare for the advanced stages of Parkinson’s and what care options are available.
An insight into the factors that influence the progression of Parkinson’s disease and how those affected can slow down the progression of the disease.
A discussion of the emotional impact of Parkinson’s, particularly depression and anxiety, and strategies to overcome these challenges.
This article highlights autonomic symptoms such as digestive and bladder problems in Parkinson’s and gives practical tips to improve quality of life.
